小 balloon 低压回拉技术对比传统策略处理PCI相关冠状动脉壁内血肿的结局
该回顾性队列研究纳入181例PCI期间发生冠状动脉壁内血肿的患者,分别接受追加支架/切割球囊、保守管理或小 balloon 低压回拉技术处理。结果显示小 balloon 低压回拉技术组住院时间最短、支架使用最少、MACE发生率最低,且心脏功能改善和心肌损伤标志物下降优于保守管理。
要点
- 小 balloon 低压回拉技术组MACE发生率为7.7%,低于追加支架组的29.4%和保守管理组的50%。
- 小 balloon 低压回拉技术组住院中位时间5.0天,短于追加支架组的7.0天和保守管理组的10.0天。
- 追加支架组支架总长度77.0 mm、支架数3.0枚,显著高于其他两组。
核心结论
- 小 balloon 低压回拉技术较传统管理可能改善心脏功能、缩短住院时间、减少支架使用并改善长期结局。
研究设计与样本
- 患者接受追加支架/切割球囊(n=109)、保守管理(n=20)或小 balloon 低压回拉技术(n=52)。
主要发现
- 术后肌钙蛋白I在追加支架/切割球囊组和小 balloon 低压回拉技术组显著下降(均p<0.05),在保守管理组显著升高(p<0.05)。
- 术后左心室射血分数在追加支架/切割球囊组和小 balloon 低压回拉技术组改善(均p<0.05),在保守管理组下降(p<0.05)。
- 中位随访15.1个月,MACE发生率小 balloon 低压回拉技术组7.7%、追加支架/切割球囊组29.4%、保守管理组50%(p<0.001)。
- 校正后风险比:小 balloon 低压回拉技术对比保守管理HR 0.060(95%CI 0.018–0.210,p<0.001);追加支架/切割球囊对比保守管理HR 0.385(95%CI 0.174–0.853,p=0.019)。
临床怎么用
- 对于PCI相关冠状动脉壁内血肿,小 balloon 低压回拉技术可作为传统追加支架或保守管理的替代选择。
局限性
- 回顾性设计,各组样本量不均衡(保守管理组仅20例),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Background and Aims The management of percutaneous coronary intervention (PCI)-related coronary intramural hematoma (CIMH) is debated. Conventional strategies—additional stenting with/without cutting balloon (AS/CB) or conservative management (CM)—have limitations. The small balloon low-pressure pullback technique (SBLP) is a newer option, but comparative evidence is limited. This study compared in-hospital and long-term outcomes among AS/CB, CM, and SBLP. Methods In this retrospective cohort study, 181 patients who developed CIMH during PCI between January 2022 and December 2025 were enrolled. Patients were managed with AS/CB (n = 109), CM (n = 20), or SBLP (n = 52). Primary endpoints included myocardial injury biomarkers (troponin I), cardiac function recovery (LVEF), stent utilization, hospitalization stay and costs, and major adverse cardiovascular events (MACEs). Results Post-procedural troponin I levels decreased significantly in the AS/CB and SBLP groups (all p < 0.05) but increased significantly in the CM group (p < 0.05). LVEF improved postoperatively in the AS/CB and SBLP groups (all p < 0.05) but decreased in the CM group (p < 0.05). Hospital stay was shortest with SBLP (median 5.0 days) versus CM (10.0) and AS/CB (7.0). Stent use was highest with AS/CB (total length 77.0 mm; 3.0 stents) versus others (p < 0.05). Over 15.1 months, MACE incidence was lowest with SBLP (7.7%) versus AS/CB (29.4%) and CM (50%; p < 0.001). Adjusted hazard ratios confirmed lower MACE risk: SBLP versus CM, HR 0.060, 95% CI 0.018–0.210, p < 0.001; AS/CB versus CM, HR 0.385, 95% CI 0.174–0.853, p = 0.019. Conclusion SBLP shows potential benefits over conventional CIMH management, with improved cardiac function, shorter hospitalization, fewer stents, and better long-term outcomes.
引用
- Catheterization and Cardiovascular Interventions:Comparative Outcomes of Novel Small Balloon Low‐Pressure Pullback and Traditional Management for Coronary Intramural Hematoma Complicating PCI
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。